BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1443053)

  • 1. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.
    Jesmok G; Lindsey C; Duerr M; Fournel M; Emerson T
    Am J Pathol; 1992 Nov; 141(5):1197-207. PubMed ID: 1443053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
    Emerson TE; Lindsey DC; Jesmok GJ; Duerr ML; Fournel MA
    Circ Shock; 1992 Oct; 38(2):75-84. PubMed ID: 1423924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; GĂ©rain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
    Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
    J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin.
    Cargile JL; MacKay RJ; Dankert JR; Skelley L
    Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC
    Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-lipopolysaccharide monoclonal antibodies inhibit macrophage TNF messenger RNA synthesis in vitro.
    Battafarano RJ; Burd RS; Cody CS; Kellogg TA; Raymond CS; Ratz CA; Dunn DL
    J Surg Res; 1993 Apr; 54(4):342-8. PubMed ID: 8331928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to tumor necrosis factor-alpha attenuates plasma interleukin-6 levels in porcine gram-negative sepsis.
    Mullen PG; Fisher BJ; Walsh CJ; Susskind BM; Leeper-Woodford SK; Jesmok GJ; Fowler AA; Sugerman HJ
    J Surg Res; 1994 Nov; 57(5):625-31. PubMed ID: 7967599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
    Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin.
    Cargile JL; MacKay RJ; Dankert JR; Skelley L
    Am J Vet Res; 1995 Nov; 56(11):1445-50. PubMed ID: 8585654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
    Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
    J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
    Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y
    J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
    Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
    J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma involvement in the severity of gram-negative infections in mice.
    Kohler J; Heumann D; Garotta G; LeRoy D; Bailat S; Barras C; Baumgartner JD; Glauser MP
    J Immunol; 1993 Jul; 151(2):916-21. PubMed ID: 8335919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.